Soft Tissue Management in Peri-Implant Regions

Ömer Alperen Kırmızıgül20 enrolled

Overview

Background:This study aimed to compare the effect of ribose cross-linked thick collagen membrane (RCCM) with that of subepithelial connective tissue graft (CTG) in sites with soft tissue deficiency in the horizontal aspect around the implant. Methods:Single implant sites were included in the study of 20 systemically healthy patients. All procedures were performed concurrently with implant placement; SCTG was administered in ten patients, and RCCM in the other ten. Before the operation, the PIMT and peri-implant mucosa width (PIMW) were measured. Visual analog scale (VAS) and Oral Health Impact profile-14 (OHIP-14) scores were recorded on post-operative days 1, 3, and 7. At 1 and 3 months measurements were repeated. Results:In terms of PIMT, an average increase of 1.87 mm was recorded in the RCCM group and 1.99 mm in the SCTG group. The rate of increase in PIMT was statistically similar in both the groups (p\>0.05). The OHIP-14 and VAS scores were similar between the groups on days 1, 3, and 7. There was a decrease at 3 months in both the groups. Conclusion:Within the limits of this study, RCCM provided a similar increase in PIMT as SCTG. RCCM is a promising alternative to SCTG for increasing the PIMT. Keywords: Collagen, Connective tissue, Dental implants, Oral mucosa

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

Conditions

Peri-implant Mucosa Thickness Peri-implant Mucosa Width

Interventions

Connective Tissue GraftOTHER

Implant treatment was performed in 20 patients with a single tooth deficiency and soft tissue deficiency in the horizontal direction in the edentulous site. All patients received bone-level titanium implants. Soft tissue augmentation was performed simultaneously with implant treatment. The group were divided into CTG , and 10 patients were randomly assigned to group.

Ribose Cross-Linked Thick Collagen MembraneOTHER

Implant treatment was performed in 20 patients with a single tooth deficiency and soft tissue deficiency in the horizontal direction in the edentulous site. All patients received bone-level titanium implants. Soft tissue augmentation was performed simultaneously with implant treatment. The groups were divided into RCCM, and 10 patients were randomly assigned to group.

Eligibility

Sex: ALLMin age: 18 YearsMax age: 60 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Systemically healthy * The edentulous space for which implant treatment is planned to be single tooth size and molar tooth site * Those with soft tissue deficiency in the horizontal aspect in the site where implant treatment is planned * Age between 18-60 years * Does not have a condition that may cause a bleeding disorder * No nausea-vomiting reflex * Patients with good oral hygiene Exclusion Criteria: * Patients with systemic disorders (diabetes, hypertension, radiotherapy/ chemotherapy, etc.) * Patients who have insufficient horizontal alveolar bone in the site where implant treatment is planned and who may lead to bone dehiscence after implant placement * Patients with collagen allergy * Those taking any medication that may affect wound healing * Those with bleeding disorders * Smokers who smoke more than 10 cigarettes a day * Poor oral hygiene * Those with vomiting-nausea reflex * Allergic to anti-inflammatory drugs * Patients with pregnancy/breastfeeding status.

Soft Tissue Management in Peri-Implant Regions

Overview

Conditions

Interventions

Eligibility

Locations (1)

Outcomes

Primary Outcomes